NEWS Medical groups raise capacities
Increasing demand across the healthcare market generated by the Covid-19 pandemic is benefiting plastics-related manufactur- ers. Global medical device group Becton Dickinson (BD) is to invest some $1.2bn over four years to expand and upgrade manufacturing capacity and technology for pre-fillable syringes and advanced drug delivery systems at its BD Pharmaceutical Systems division. This includes product innovations, manufacturing technology enhancements and business continuity improvements. The investment will be
spread across six facilities at: Columbus, Nebraska, US; Cuautitlán, Mexico; Fuku- shima, Japan; Le Pont-de- Claix, France; Swindon, UK; and Tatabánya, Hungary. The company will also add a new manufacturing facility in Europe, which is expected to be operational by the end of 2023.
BD anticipates a surge in
Above: BD is to invest $1.2bn over four years to increase manufacturing capacity for pre-fillable syringes
demand for pre-fillable syringes during the Covid- 19 pandemic and in the longer term, as more injectable drugs and vaccines for other therapies become available.
Injection moulders in the medical sector are also experiencing increased business. Gerresheimer is increasing small batch production for plastic medical devices at its Technical Competence Centre in Wackersdorf, Germany. Products include patch pumps for administer- ing medication, drug
containers for injection without needles, point-of- care tests, infusion sets for X-ray contrast agents and syringes, among others. It has converted an
existing production area into a 500 m2
Class 7 and 8
cleanroom space and has constructed a new building with 1,200 m2
of additional
cleanroom and office space. After this, it will have 2,200 m2
of space for cleanroom
plastic production and 2,900 m2
for all small batch
production. UK-based Carclo said its Technical Plastics (CTP)
division has signed a framework agreement with a major global OEM for the manufacture of complex medical diagnostic dispos- able devices. The group said that it will make “significant capital invest- ment” this year to ensure that sufficient capacity is available. It expects to reach full production volumes in the second half of the 2021-2 financial year. Under this agreement,
production contracts can be awarded to CTP over the next ten years for the manufacture of a range of products. Some have already been granted and are expected to “make a modest contribution to group performance” in the current financial year. At full rate production, the deal should deliver incremental annual revenues of £10-15m per year for as long as the contract lasts. �
www.bd.com �
www.gerresheimer.com �
www.carclo.co.uk
SAIC Motor picks Styrolution ASA
MG Linghang was launched in October 2020 8 INJECTION WORLD | January/February 2021
Chinese state-owned automotive OEM SAIC Motor is using Ineos Styrolution’s Luran S 778T SPF30 grade of ASA for the front grille of its MG Linghang model, which was launched in October 2020. The two companies have already worked together for ten years. According to Styrolution, the key criteria for this decision were the grade’s enhanced UV resistance, weatherability and paint-free, high gloss appear- ance with mould-in deep dark colour. Luran S, it said, offers a combination of long-term use and a high-quality surface appearance, such as weathering stability for outdoor applications even when unpainted. �
https://www.ineos-styrolution.com/
index.html
www.injectionworld.com
IMAGE: SAIC
IMAGE: BD
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
